Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 39 / 2025
Date of issue: 2025-09-18
Short name of the issuer
KRKA
Subject
Constitutive session of the Supervisory Board of Krka, d. d., Novo mesto
Official market - legal basis
Art. 17 ust. 1 MAR
Unofficial market - legal basis
Contents of the report:
In accordance with the Ljubljana Stock Exchange Rules and Article 130 of the Market in Financial Instruments Act, company Krka, d. d., Novo mesto hereby publishes the following notice:

At its constitutive session held on 17 September 2025, the Supervisory Board of Krka, d. d., Novo mesto elected Jože Mermal as a President of the Supervisory Board and prof. dr. Juliana Kristl as a Deputy President, shareholder representative. Second Deputy President of the Supervisory Board, a representative of employees, is dr. Mateja Vrečer, elected in June 2024.

The notice will be published on the Company's website (www.krka.biz) from 18 September 2025 onwards, for a minimum period of 5 years.
Annexes
File Description

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-09-18 Jože Colarič President of the Management Board and CEO